Skip to content

Manufacturing & Operations

Precision at Scale

Manufacturing is where precision becomes practice. Every stage of production is designed to deliver consistent quality, reliable supply, and scalable capacity for both prescription and over-the-counter medicines serving the U.S. healthcare system.

Our operations combine advanced technology, disciplined execution, and strict regulatory compliance to ensure every product is manufactured with accuracy and control. From formulation and analytical testing through manufacturing, packaging, and distribution, each step is managed with precision to deliver dependable outcomes patients and partners can trust. Our expertise includes advanced modified-release technologies, such as osmotic drug delivery systems, which enable controlled, predictable release profiles that enhance product performance and patient experience.

Our U.S. operations are anchored by a state-of-the-art manufacturing and R&D facility in Chantilly, Virginia, complemented by dedicated packaging and distribution capabilities in Manassas, Virginia. Together, these facilities provide an integrated domestic platform that strengthens responsiveness to the U.S. market while reinforcing quality, speed, and supply reliability.

Supporting these operations is a global manufacturing network that includes seven manufacturing facilities in India producing active pharmaceutical ingredients (APIs) and finished dosage products. This vertically integrated footprint provides the scale, flexibility, and supply continuity needed to serve customers with confidence. By combining U.S. manufacturing and distribution with global production expertise, Granules delivers the reliability, resilience, and consistency our partners depend on.

Manufacturing Capabilities

  • Immediate-release tablets and capsules
  • Multi-particulate pellet-based modified-release dosage forms 
  • Delayed-release and extended-release tablet and capsule dosage forms
  • Osmotic-controlled release dosage forms
  • Orally disintegrating modified-release dosage forms
  • Chewable modified-release dosage forms
  • Microsphere-based technology platform
  • Powders for reconstitution into oral solutions (including packaging)
  • Modified-release suspensions
  • Private-label over-the-counter (OTC) products